arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Tectonic Therapeutic, Inc.

TECX
$24.93 ▼ -1.63 (-6.14%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
38 Visible periods
25 Metrics
Peer-ranked Benchmarks
Price Chart
32
Health
Poor
Bearish
auto_awesome

Analytical Summary

Tectonic Therapeutic, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $472.8M
Dividend Yield
Revenue Growth
Op. Margin
ROIC -10.9%
FCF / Share $-1.14
Trailing P/E
Price / Book 2.1x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

38-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-25.24M
↓ -58.7%
FCF / Share Free cash flow per share
$-1.14
↓ -15.6%
Long-Term Debt Long-term obligations
$15.00M
— 0.0%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
23
Cash Quality
55

Dividend History

Dividend / share · sourced from SEC filings
$0.00 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 10 years · 38 quarters